Cargando…
Impact of neutrophil-to-lymphocyte ratio on periprocedural myocardial infarction in patients undergoing non-urgent percutaneous coronary revascularisation
BACKGROUND: Pro-thrombotic conditions importantly influence myocardial perfusion and procedural results after percutaneous coronary intervention (PCI). The neutrophil-to-lymphocyte ratio (NLR) has emerged as a predictor of cardiovascular events and of long-term prognosis, especially in ST-elevation...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Bohn Stafleu van Loghum
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4943889/ https://www.ncbi.nlm.nih.gov/pubmed/27277659 http://dx.doi.org/10.1007/s12471-016-0850-6 |
_version_ | 1782442663897726976 |
---|---|
author | Verdoia, M. Schaffer, A. Barbieri, L. Di Giovine, G. Bellomo, G. Marino, P. Suryapranata, H. De Luca, G. |
author_facet | Verdoia, M. Schaffer, A. Barbieri, L. Di Giovine, G. Bellomo, G. Marino, P. Suryapranata, H. De Luca, G. |
author_sort | Verdoia, M. |
collection | PubMed |
description | BACKGROUND: Pro-thrombotic conditions importantly influence myocardial perfusion and procedural results after percutaneous coronary intervention (PCI). The neutrophil-to-lymphocyte ratio (NLR) has emerged as a predictor of cardiovascular events and of long-term prognosis, especially in ST-elevation myocardial infarction patients undergoing primary PCI. The aim of our study was to evaluate the role of NLR on periprocedural myocardial infarction (MI) in patients undergoing non-urgent PCI. METHODS: In a consecutive cohort of 1542 patients undergoing PCI, myonecrosis biomarkers were determined at 6, 12, 24 and 48 hours post-procedure. Patients were divided into quintiles according to NLR values. Periprocedural myonecrosis was defined as a troponin I increase of 3 times the upper limit of normal or as 50 % of an elevated baseline value, whereas periprocedural MI was defined as a CK-MB increase of 3 times the upper limit of normal or 50 % of baseline. RESULTS: Higher NLR was related to age, established risk factors and cardiovascular history. NLR was associated with severe coronary artery disease (p = 0.009), tighter stenosis (p < 0.001), coronary calcifications (p = 0.005), intracoronary thrombus or thrombectomy use (p < 0.001), TIMI flow pre- and post-PCI (p < 0.001), and inversely to restenosis (p = 0.04) and use of a drug-eluting stent (p = 0.001). NLR did not influence the occurrence of myonecrosis (p = 0.75; adjusted OR (95 % CI) = 0.99 (0.63–1.54), p = 0.96), but was associated with a higher occurrence of periprocedural MI, even after correction for baseline differences (p = 0.03; adjusted OR (95 % CI) = 1.33 (1.02–2.3), p = 0.02), with NLR ≥ 3 best predicting the risk of periprocedural MI at the receiver operating characteristic curve analysis. CONCLUSION: In patients undergoing non-urgent PCI, a higher NLR increases the risk of periprocedural MI, especially for values ≥ 3. |
format | Online Article Text |
id | pubmed-4943889 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | Bohn Stafleu van Loghum |
record_format | MEDLINE/PubMed |
spelling | pubmed-49438892016-07-26 Impact of neutrophil-to-lymphocyte ratio on periprocedural myocardial infarction in patients undergoing non-urgent percutaneous coronary revascularisation Verdoia, M. Schaffer, A. Barbieri, L. Di Giovine, G. Bellomo, G. Marino, P. Suryapranata, H. De Luca, G. Neth Heart J Original Article - E‑Learning BACKGROUND: Pro-thrombotic conditions importantly influence myocardial perfusion and procedural results after percutaneous coronary intervention (PCI). The neutrophil-to-lymphocyte ratio (NLR) has emerged as a predictor of cardiovascular events and of long-term prognosis, especially in ST-elevation myocardial infarction patients undergoing primary PCI. The aim of our study was to evaluate the role of NLR on periprocedural myocardial infarction (MI) in patients undergoing non-urgent PCI. METHODS: In a consecutive cohort of 1542 patients undergoing PCI, myonecrosis biomarkers were determined at 6, 12, 24 and 48 hours post-procedure. Patients were divided into quintiles according to NLR values. Periprocedural myonecrosis was defined as a troponin I increase of 3 times the upper limit of normal or as 50 % of an elevated baseline value, whereas periprocedural MI was defined as a CK-MB increase of 3 times the upper limit of normal or 50 % of baseline. RESULTS: Higher NLR was related to age, established risk factors and cardiovascular history. NLR was associated with severe coronary artery disease (p = 0.009), tighter stenosis (p < 0.001), coronary calcifications (p = 0.005), intracoronary thrombus or thrombectomy use (p < 0.001), TIMI flow pre- and post-PCI (p < 0.001), and inversely to restenosis (p = 0.04) and use of a drug-eluting stent (p = 0.001). NLR did not influence the occurrence of myonecrosis (p = 0.75; adjusted OR (95 % CI) = 0.99 (0.63–1.54), p = 0.96), but was associated with a higher occurrence of periprocedural MI, even after correction for baseline differences (p = 0.03; adjusted OR (95 % CI) = 1.33 (1.02–2.3), p = 0.02), with NLR ≥ 3 best predicting the risk of periprocedural MI at the receiver operating characteristic curve analysis. CONCLUSION: In patients undergoing non-urgent PCI, a higher NLR increases the risk of periprocedural MI, especially for values ≥ 3. Bohn Stafleu van Loghum 2016-06-08 2016-07 /pmc/articles/PMC4943889/ /pubmed/27277659 http://dx.doi.org/10.1007/s12471-016-0850-6 Text en © The Author(s) 2016 Open Access. This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. |
spellingShingle | Original Article - E‑Learning Verdoia, M. Schaffer, A. Barbieri, L. Di Giovine, G. Bellomo, G. Marino, P. Suryapranata, H. De Luca, G. Impact of neutrophil-to-lymphocyte ratio on periprocedural myocardial infarction in patients undergoing non-urgent percutaneous coronary revascularisation |
title | Impact of neutrophil-to-lymphocyte ratio on periprocedural myocardial infarction in patients undergoing non-urgent percutaneous coronary revascularisation |
title_full | Impact of neutrophil-to-lymphocyte ratio on periprocedural myocardial infarction in patients undergoing non-urgent percutaneous coronary revascularisation |
title_fullStr | Impact of neutrophil-to-lymphocyte ratio on periprocedural myocardial infarction in patients undergoing non-urgent percutaneous coronary revascularisation |
title_full_unstemmed | Impact of neutrophil-to-lymphocyte ratio on periprocedural myocardial infarction in patients undergoing non-urgent percutaneous coronary revascularisation |
title_short | Impact of neutrophil-to-lymphocyte ratio on periprocedural myocardial infarction in patients undergoing non-urgent percutaneous coronary revascularisation |
title_sort | impact of neutrophil-to-lymphocyte ratio on periprocedural myocardial infarction in patients undergoing non-urgent percutaneous coronary revascularisation |
topic | Original Article - E‑Learning |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4943889/ https://www.ncbi.nlm.nih.gov/pubmed/27277659 http://dx.doi.org/10.1007/s12471-016-0850-6 |
work_keys_str_mv | AT verdoiam impactofneutrophiltolymphocyteratioonperiproceduralmyocardialinfarctioninpatientsundergoingnonurgentpercutaneouscoronaryrevascularisation AT schaffera impactofneutrophiltolymphocyteratioonperiproceduralmyocardialinfarctioninpatientsundergoingnonurgentpercutaneouscoronaryrevascularisation AT barbieril impactofneutrophiltolymphocyteratioonperiproceduralmyocardialinfarctioninpatientsundergoingnonurgentpercutaneouscoronaryrevascularisation AT digiovineg impactofneutrophiltolymphocyteratioonperiproceduralmyocardialinfarctioninpatientsundergoingnonurgentpercutaneouscoronaryrevascularisation AT bellomog impactofneutrophiltolymphocyteratioonperiproceduralmyocardialinfarctioninpatientsundergoingnonurgentpercutaneouscoronaryrevascularisation AT marinop impactofneutrophiltolymphocyteratioonperiproceduralmyocardialinfarctioninpatientsundergoingnonurgentpercutaneouscoronaryrevascularisation AT suryapranatah impactofneutrophiltolymphocyteratioonperiproceduralmyocardialinfarctioninpatientsundergoingnonurgentpercutaneouscoronaryrevascularisation AT delucag impactofneutrophiltolymphocyteratioonperiproceduralmyocardialinfarctioninpatientsundergoingnonurgentpercutaneouscoronaryrevascularisation |